Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
NCT06270576
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Asthma; Eosinophilic
Asthma
Interventions
DRUG:
Lipopolysaccharides
Sponsor
National Jewish Health